Thrombopoietin Receptor Agonists: Can These Be the Future Answer to the Deadly Thrombocytopenia in Dengue Fever? | Cureus;11(4): e4361, 2019 Apr 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Thrombopoietin Receptor Agonists: Can These Be the Future Answer to the Deadly Thrombocytopenia in Dengue Fever?

Roy, Sayak.

Affiliation

Roy S; Internal Medicine, Calcutta Medical Research Institute Hospital, Kolkata, IND.

Cureus ; 11(4): e4361, 2019 Apr 01.

Article in En | MEDLINE | ID: mdl-31192066

Key words

dengue; immune thrombocytopenic purpura; thrombocytopenia; thrombopoietin receptor agonists

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Cureus Year: 2019 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Cureus Year: 2019 Document type: Article Country of publication: United States